283 related articles for article (PubMed ID: 19231294)
1. Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.
Ko MC; Naughton NN
J Pain; 2009 May; 10(5):509-16. PubMed ID: 19231294
[TBL] [Abstract][Full Text] [Related]
2. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
Ding H; Hayashida K; Suto T; Sukhtankar DD; Kimura M; Mendenhall V; Ko MC
Br J Pharmacol; 2015 Jul; 172(13):3302-12. PubMed ID: 25752320
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.
Hu E; Calò G; Guerrini R; Ko MC
Pain; 2010 Jan; 148(1):107-113. PubMed ID: 19945794
[TBL] [Abstract][Full Text] [Related]
4. Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies.
Ko MC; Wei H; Woods JH; Kennedy RT
J Pharmacol Exp Ther; 2006 Sep; 318(3):1257-64. PubMed ID: 16766718
[TBL] [Abstract][Full Text] [Related]
5. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
7. Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
Lee H
Yonsei Med J; 2013 May; 54(3):763-71. PubMed ID: 23549827
[TBL] [Abstract][Full Text] [Related]
8. Effect of intrathecal nocistatin on nociceptin/orphanin FQ analgesia in chronic constriction injury rat.
Ma F; Xie H; Dong ZQ; Wang YQ; Wu GC
Brain Res; 2003 Oct; 988(1-2):189-92. PubMed ID: 14519541
[TBL] [Abstract][Full Text] [Related]
9. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
[TBL] [Abstract][Full Text] [Related]
10. Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates.
Cremeans CM; Gruley E; Kyle DJ; Ko MC
J Pharmacol Exp Ther; 2012 Oct; 343(1):72-81. PubMed ID: 22743574
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity.
Micheli L; Di Cesare Mannelli L; Rizzi A; Guerrini R; Trapella C; Calò G; Ghelardini C
Eur J Pharmacol; 2015 Nov; 766():155-62. PubMed ID: 26450087
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
[TBL] [Abstract][Full Text] [Related]
13. Functional Profile of Systemic and Intrathecal Cebranopadol in Nonhuman Primates.
Ding H; Trapella C; Kiguchi N; Hsu FC; Caló G; Ko MC
Anesthesiology; 2021 Sep; 135(3):482-493. PubMed ID: 34237134
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
[TBL] [Abstract][Full Text] [Related]
15. An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception.
Ko MC; Naughton NN
Anesthesiology; 2000 Mar; 92(3):795-805. PubMed ID: 10719958
[TBL] [Abstract][Full Text] [Related]
16. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
[TBL] [Abstract][Full Text] [Related]
17. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.
Heinricher MM; McGaraughty S; Grandy DK
J Neurophysiol; 1997 Dec; 78(6):3351-8. PubMed ID: 9405549
[TBL] [Abstract][Full Text] [Related]
18. BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.
Kiguchi N; Ding H; Cami-Kobeci G; Sukhtankar DD; Czoty PW; DeLoid HB; Hsu FC; Toll L; Husbands SM; Ko MC
Br J Anaesth; 2019 Jun; 122(6):e146-e156. PubMed ID: 30916003
[TBL] [Abstract][Full Text] [Related]
19. Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.
Ko MC; Naughton NN; Traynor JR; Song MS; Woods JH; Rice KC; McKnight AT
Br J Pharmacol; 2002 Feb; 135(4):943-50. PubMed ID: 11861322
[TBL] [Abstract][Full Text] [Related]
20. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys.
Rizzi A; Sukhtankar DD; Ding H; Hayashida K; Ruzza C; Guerrini R; Calò G; Ko MC
Br J Pharmacol; 2015 Jul; 172(14):3661-70. PubMed ID: 25828800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
